Expired Tender Germany ICB TOT Ref. 20231870

Contract notice: Other nervous system medicinal Tender - 20231870

Tender notice from Germany, published on 02 Feb 2018.

Executive Summary

The AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN has issued a Tender notice for the procurement of a Contract notice: Other nervous system medicinal products in the Germany. This Tender notice was published on 02 Feb 2018 and is scheduled to close on 26 Jan 2020, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 20231870, while the tender notice number is 043491-2018 and Register on the platform.

Key facts

Summary
Contract notice: Other nervous system medicinal products
TOT Ref. No.
20231870
Document Ref. No.
043491-2018
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
02 Feb 2018
Bid deadline
26 Jan 2020
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Other nervous system medicinal products
Description: Contract notice: Other nervous system medicinal products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 33661700, 33661700
CPV Description: Conclusion of a non-exclusive discount agreement according to - 130a Abs. 8 SGB V on medicines containing the active ingredient pyridostigmine (ATC code: N07AA02)
Conclusion of a non-exclusive discount agreement according to - 130a Abs. 8 SGB V on medicines with the active substance pyridostigmine (ATC code: N07AA02) within the period from 1.4.2018 to 31.3.2020 with an-Possibility of contracting during the term ("open-house model").
For the active substance pyridostigmine (ATC code: N07AA02) the AOK offers the health insurance for Lower Saxony for the period up to the entry into force of exclusive contracts as a result of a contract award procedure Regulations of the 4th part of the GWB all interested pharmaceutical companies, without AuswSelection decision, discount contracts. The contracts are concluded within the framework of an "open-house model" and act as a bridge between the start of generic competition (patent expiration) and the awarding of exclusive contracts.The contracts offered are not exclusive, contracts with all market participants (pharmaceutical companies) are part of the contract AOK Lower Saxony wanted, In the open-house model, uniform conditions apply to all participants. Contractual content, conditions and access procedures are uniform. Individual negotiations are generally not conducted. The contract terms are a maximum of twenty-four months, the earliest date of contract is 1.4.2018. All contracts end at the latest on 31.3.2020, regardless of the date of eachconclusion of contract. An accession or a contract can be made within the twenty-four month period on the first of each month. There is a right to cancel six weeks to the end of each month. The AOK The health fund for Lower Saxony reserves itself, already during the contract the non-exclusive open-house discount contracts by exclusive Rabsubstitute contracts. With the entry into force of exclusive tender agreements, the open-house contracts will be terminated in accordance with the contractual arrangements, ie. H. the open-house contracts end automatically. According to the experience of the AOK Niedersachsen, exclusive rebate contracts usually take place six to eight months after the publication of the corresponding tender offerin the Supplement to the Official Journal of the European Union. Future contractors in the open-house model are invited to regularly consult the Supplement to the Official Journal of the European Union for these calls for tenders.
Interested pharmaceutical companies may consult the contract documents and conditions under I.1) gRequest the contact address.
Contracts for the active substance pyridostigmine (ATC code: N07AA02) will be concluded for the first time with effect from 1.4.2018. Interested parties wishing to become contract partners on this date must submit the contract documents to be submitted by 25.2.2018 at the address specified in the contract documents. It depends on the access at the AOK Lower Saxony-at. Later contract terms are possible during the twenty-four month maximum term on the first of each month. Organizationally, an advance of usually 35 calendar days on the part of the AOK is necessary to the necessary work, eg. B. the contract message in the Lauer tax (r) to ensure. The exact deadlines are announced with the contract documentsgiven. This publication does not constitute a public contract within the meaning of the Procurement Coordination Directive (2004/18 / EC) or public procurement law. In order to ensure the widest possible degree of transparency for the intended conclusion of the contract, it is published in the Supplement to the Official Journal of the European Union. In the absence eThe contract notice will be used in the corresponding publication form. The resulting conceptual requirements, such as the process name "open procedure", are solely due to the use of this announcement form and the publication platform.Another meaning, in particular a submission of subcontracting regulations, as far as they are concerned-are not obligatory for legal reasons, is not connected with it
Internet address (URL): www.aok.de
Directive: Classical Directive (2014/24/EU)

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Other nervous system medicinal products was 26 Jan 2020. Bidding is closed.

This tender has been issued by AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33661700 - Other nervous system medicinal products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 20231870. The purchaser document reference is 043491-2018.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.